These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7452666)

  • 1. Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity on L1210 leukemic cells in vitro and in vivo.
    Baurain R; Masquelier M; Deprez-De Campeneere D; Trouet A
    J Med Chem; 1980 Nov; 23(11):1171-4. PubMed ID: 7452666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestion.
    Masquelier M; Baurain R; Trouet A
    J Med Chem; 1980 Nov; 23(11):1166-70. PubMed ID: 7452665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
    Trouet A; Masquelier M; Baurain R; Deprez-De Campeneere D
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):626-9. PubMed ID: 6952214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model.
    Pan XQ; Lee RJ
    Anticancer Res; 2005; 25(1A):343-6. PubMed ID: 15816557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular uptake and metabolism of daunorubicin as determined by high-performance liquid chromatography. Application to L1210 cells.
    Baurain R; Zenebergh A; Trouet A
    J Chromatogr; 1978 Sep; 157():331-6. PubMed ID: 568150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular pharmacology of detorubicin and doxorubicin in L1210 cells.
    Zenebergh A; Baurain R; Trouet A
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):115-21. PubMed ID: 6537910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileukemic activity of 4-demethoxydaunorubicin in mice.
    Casazza AM; Pratesi G; Giuliani F; Di Marco A
    Tumori; 1980 Oct; 66(5):549-64. PubMed ID: 6936969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.
    Chervinsky DS; Wang JJ
    J Med; 1976; 7(1):63-79. PubMed ID: 1064679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of new N-substituted daunorubicin derivatives.
    Mazerska Z; Woynarowska B; Stefanska B; Borowski E; Martelli S
    Drugs Exp Clin Res; 1987; 13(6):345-51. PubMed ID: 3308387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, therapeutic efficacy and intratumoral localization of targeted daunorubicin liposomes conjugating folate-PEG-CHEMS.
    Xiong S; Yu B; Wu J; Li H; Lee RJ
    Biomed Pharmacother; 2011 Feb; 65(1):2-8. PubMed ID: 21177069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).
    Woodman RJ; Cysyk RL; Kline I; Gang M; Venditti JM
    Cancer Chemother Rep; 1975; 59(4):689-95. PubMed ID: 1175163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular pharmacology and antitumor activity of N-(p-azidobenzoyl)-daunorubicin, a photoactive anthracycline analogue.
    Averbuch SD; Clawson RE; Bachur NR; Felsted RL
    Cancer Chemother Pharmacol; 1986; 16(3):211-7. PubMed ID: 2421935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
    Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
    Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes.
    Deprez-De Campeneere D; Baurain R; Huybrechts M; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):25-30. PubMed ID: 498415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
    Deprez-de Campeneere D; Baurain R; Trouet A
    Cancer Treat Rep; 1979 May; 63(5):861-7. PubMed ID: 455327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular pharmocodynamics of several anthrocycline antibiotics.
    Bachur NR; Steele M; Meriwether WD; Hildebrand RC
    J Med Chem; 1976 May; 19(5):651-4. PubMed ID: 1271407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic study of leukemia by pegylated liposomal daunorubicin].
    Zhang Y; Zhang X; Tang W; Ma J
    Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):746-50. PubMed ID: 25567304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
    Adams EG; Bhuyan BK
    Cancer Res; 1986 Dec; 46(12 Pt 1):6125-30. PubMed ID: 2946401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.
    Arcamone F; Bernardi L; Giardino P; Patelli B; Marco A; Casazza AM; Pratesi G; Reggiani P
    Cancer Treat Rep; 1976 Jul; 60(7):829-34. PubMed ID: 1009518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumor.
    Skovsgaard T
    Cancer Res; 1980 Apr; 40(4):1077-83. PubMed ID: 7357538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.